Growth & profitability
- Operating margin has expanded, at 425.6% in the latest year.
Financial health
- The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
6 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | -$39M | -$87M | 0.0% | 425.6% | 46.2% | -36.6% | -$39M | — | $3M |
| 2025 | -$8M | $51M | 0.0% | 304.5% | -146.5% | 14.4% | -$39M | — | $1M |
| 2024 | -$99M | -$2.1B | 0.0% | 2683.5% | 1090.8% | -568.7% | -$60M | — | $8M |
| 2023 | -$105M | -$131M | 0.0% | 241.3% | -7.6% | -4.5% | -$97M | — | $9M |
| 2021 | $55M | -$63M | 0.0% | -128.6% | -5.8% | — | -$61M | — | — |
| 2020 | $140M | -$58M | 0.0% | -33.8% | -5.9% | — | -$57M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $12M | -$7M | 0.0% | -3.1% | 3.7% | -2.7% | -$4M | — | $6M |
| Mar '26 | -$42M | -$39M | 0.0% | 141.3% | 20.4% | -16.2% | -$4M | — | $3M |
| Dec '25 | $19M | $20M | 0.0% | 21.1% | -15.5% | 5.9% | -$9M | — | $8M |
| Sep '25 | -$3M | — | 0.0% | 646.5% | 0.0% | 0.0% | -$15M | — | $5M |
| Jun '25 | -$13M | -$65M | 0.0% | 734.0% | 54.1% | -19.5% | -$11M | — | $8M |
| Mar '25 | -$31M | -$780000 | 0.0% | 146.3% | 2.2% | -0.2% | -$9M | — | $1M |
| Dec '24 | $4M | -$9M | 0.0% | -215.3% | -60.6% | -2.2% | -$10M | — | $4M |
| Sep '24 | $9M | — | 0.0% | -160.2% | 0.0% | 0.0% | -$9M | — | $4M |
| Jun '24 | $10M | — | 0.0% | 441.3% | 0.0% | 0.0% | -$11M | — | $4M |
| Mar '24 | -$43M | — | 0.0% | 453.6% | 0.0% | 0.0% | -$9M | — | $8M |
| Dec '23 | -$10M | — | 0.0% | 8949.2% | 0.0% | 0.0% | -$23M | — | $11M |
| Sep '23 | -$43M | — | 0.0% | 892.8% | 0.0% | 0.0% | -$14M | — | $2M |
| Jun '23 | -$3M | — | 0.0% | 42142.5% | 0.0% | 0.0% | -$14M | — | $3M |
| Mar '23 | -$18M | — | 0.0% | 265.4% | 0.0% | 0.0% | -$22M | — | $9M |
| Dec '22 | -$11M | — | 0.0% | 395.0% | 0.0% | — | -$14M | — | — |
| Sep '22 | -$38M | — | 0.0% | 192.4% | 0.0% | — | -$24M | — | — |
| Jun '22 | -$37M | — | 0.0% | 232.0% | 0.0% | — | -$37M | — | — |
| Mar '22 | -$67M | -$44M | 0.0% | 149.9% | -2.3% | -1.4% | -$12M | — | $71M |
| Mar '21 | $2M | — | 0.0% | -983.0% | 0.0% | — | -$18M | — | — |
How the market has priced BENF against its own fundamentals since 2023-06 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
See the revenue and net-income charts above for Beneficient's multi-year trend.
As of FY2026, Beneficient reported — of total debt against $3M of cash.
In FY2026, gross margin was —, operating margin 425.6%, and net margin 223.5%.
As of Sep '26, Beneficient traded at a price-to-earnings ratio of about 6.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.